NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000454

Registered date:01/08/2006

A study on preventive effect of cilostazol against deterioration of symptoms in acute stage of lacunar infarctions

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedischemic stroke
Date of first enrollment2006/08/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)administered aspirin of 200mg orally for 14days administered aspirin of 200mg and cilostazol of 200mg orally for 14days.

Outcome(s)

Primary OutcomeActivity of Daily Living of 14days after onset which is assessed by modified Rankin Scale and Barthel Index
Secondary OutcomeNIHSS: 7 and 14days after the admission JSS: 7 and 14days after the admission JSS-M: 7 and 14days after the admission Barthel Index: 7 and 14days after the admission

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriapatients with active bleeding or bleeding tendency chronic heart falure peptic ulcer anemia leukocytopenia thrombocytopenia liver dysfunction renal dysfunction neoplastic disorders allergy to aspirin or cilostazol asthma caused by aspirin patients taking antiplatelet drugs, anticoagulants or NSAIDS

Related Information

Contact

public contact
Name Yasuhiro Ishibashi
Address 19-1 Uchimaru, Morioka, Iwate, Japan Japan
Telephone 019-651-5111
E-mail yasubasi@iwate-med.ac.jp
Affiliation Iwate Medical University Department of Neurology
scientific contact
Name Yasuo Terayama
Address 19-1 Uchimaru, Morioka, Iwate, Japan Japan
Telephone 019-651-5111
E-mail
Affiliation Iwate Medical University Department of Neurology